StockData
Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc. (XENE) stock

XENENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$38.78−0.48 (-1.22%)

Close on Nov 17, 2026Market cap $3.76BP/E –Yield –

Earnings

Xenon Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 25, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$1.11
-$1.15 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Xenon Pharmaceuticals's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Feb 25, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 9, 2026after the close––-$1.11Release
Q2 FY2026ended Jun 30, 2026Aug 6, 2026after the close––-$1.11Release
Q1 FY2026ended Mar 31, 2026May 7, 2026after the close––-$1.17Release
Q4 FY2025ended Dec 31, 2025Feb 26, 2026after the close–––Release
Q3 FY2025ended Sep 30, 2025Nov 3, 2025after the close––-$1.15Release
Q2 FY2025ended Jun 30, 2025Aug 11, 2025after the close––-$1.07Release
Q1 FY2025ended Mar 31, 2025May 12, 2025after the close$7.50M––Release
Q4 FY2024ended Dec 31, 2024Feb 27, 2025after the close–––Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024after the close––-$0.81Release
Q2 FY2024ended Jun 30, 2024Aug 8, 2024after the close––-$0.75Release
Q1 FY2024ended Mar 31, 2024May 9, 2024after the close––-$0.62Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Xenon Pharmaceuticals has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Xenon Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Xenon Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. News
  5. Update
  6. Update
  7. Results
  8. Results
  9. News
  10. Results
  11. Results
  12. News
  13. Results
  14. Results
  15. Results

See a number that looks wrong?